Phase I dose escalation and safety study of a semi-solid matrix (SSM) formulation of oral irinotecan and capecitabine tablets in patients with advanced solid tumors
2004 ◽
Vol 22
(14_suppl)
◽
pp. 2042-2042
◽
Keyword(s):
Phase I
◽
2020 ◽
Vol 19
(5)
◽
pp. 1210-1217
◽